世界の遺伝性遺伝性疾患用遺伝子治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Gene Therapy for Inherited Genetic Disorders Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4248 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、遺伝性遺伝性疾患用遺伝子治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（眼疾患、造血系疾患、中枢神経系疾患、筋肉疾患、その他）、用途別市場規模（病院、診療所、研究所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・遺伝性遺伝性疾患用遺伝子治療の市場動向 ・企業の競争状況、市場シェア ・遺伝性遺伝性疾患用遺伝子治療の種類別市場規模と予測2016-2027（眼疾患、造血系疾患、中枢神経系疾患、筋肉疾患、その他） ・遺伝性遺伝性疾患用遺伝子治療の用途別市場規模と予測2016-2027（病院、診療所、研究所、その他） ・遺伝性遺伝性疾患用遺伝子治療の北米市場規模2016-2027（アメリカ、カナダ） ・遺伝性遺伝性疾患用遺伝子治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・遺伝性遺伝性疾患用遺伝子治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・遺伝性遺伝性疾患用遺伝子治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・遺伝性遺伝性疾患用遺伝子治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（BioMarin Pharmaceutical Inc.、bluebird bio Inc.、Novartis AG、Orchard Therapeutics Plc、Spark Therapeutics Inc.） ・結論

In the medicine field gene therapy (also called human gene transfer) is the therapeutic delivery of nucleic acid into a patient’s cells as a drug to treat disease.A genetic disorder is a genetic problem caused by one or more abnormalities formed in the genome.
Gene therapy has the potential to cure inherited diseases that cannot be cured using conventional drugs. It is being increasingly adopted in clinical trials because of its high efficacy and safety towards the treatment of inherited genetic disorders.

Market Analysis and Insights: Global Gene Therapy for Inherited Genetic Disorders Market
The global Gene Therapy for Inherited Genetic Disorders market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Gene Therapy for Inherited Genetic Disorders market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Gene Therapy for Inherited Genetic Disorders market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Gene Therapy for Inherited Genetic Disorders market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Gene Therapy for Inherited Genetic Disorders market.

Global Gene Therapy for Inherited Genetic Disorders Scope and Market Size
Gene Therapy for Inherited Genetic Disorders market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Gene Therapy for Inherited Genetic Disorders market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Eye Disorders
Hematological Disorders
Central Nervous System Disorders
Muscular Disorders
Others

Segment by Application
Hospital
Clinic
Research Institute
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
BioMarin Pharmaceutical Inc.
bluebird bio Inc.
Novartis AG
Orchard Therapeutics Plc
Spark Therapeutics Inc.

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Therapy for Inherited Genetic Disorders Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Eye Disorders
1.2.3 Hematological Disorders
1.2.4 Central Nervous System Disorders
1.2.5 Muscular Disorders
1.2.6 Others
1.3 Market by Application
1.3.1 Global Gene Therapy for Inherited Genetic Disorders Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Research Institute
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Gene Therapy for Inherited Genetic Disorders Market Perspective (2016-2027)
2.2 Gene Therapy for Inherited Genetic Disorders Growth Trends by Regions
2.2.1 Gene Therapy for Inherited Genetic Disorders Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Gene Therapy for Inherited Genetic Disorders Historic Market Share by Regions (2016-2021)
2.2.3 Gene Therapy for Inherited Genetic Disorders Forecasted Market Size by Regions (2022-2027)
2.3 Gene Therapy for Inherited Genetic Disorders Industry Dynamic
2.3.1 Gene Therapy for Inherited Genetic Disorders Market Trends
2.3.2 Gene Therapy for Inherited Genetic Disorders Market Drivers
2.3.3 Gene Therapy for Inherited Genetic Disorders Market Challenges
2.3.4 Gene Therapy for Inherited Genetic Disorders Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Gene Therapy for Inherited Genetic Disorders Players by Revenue
3.1.1 Global Top Gene Therapy for Inherited Genetic Disorders Players by Revenue (2016-2021)
3.1.2 Global Gene Therapy for Inherited Genetic Disorders Revenue Market Share by Players (2016-2021)
3.2 Global Gene Therapy for Inherited Genetic Disorders Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Gene Therapy for Inherited Genetic Disorders Revenue
3.4 Global Gene Therapy for Inherited Genetic Disorders Market Concentration Ratio
3.4.1 Global Gene Therapy for Inherited Genetic Disorders Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy for Inherited Genetic Disorders Revenue in 2020
3.5 Gene Therapy for Inherited Genetic Disorders Key Players Head office and Area Served
3.6 Key Players Gene Therapy for Inherited Genetic Disorders Product Solution and Service
3.7 Date of Enter into Gene Therapy for Inherited Genetic Disorders Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Gene Therapy for Inherited Genetic Disorders Breakdown Data by Type
4.1 Global Gene Therapy for Inherited Genetic Disorders Historic Market Size by Type (2016-2021)
4.2 Global Gene Therapy for Inherited Genetic Disorders Forecasted Market Size by Type (2022-2027)

5 Gene Therapy for Inherited Genetic Disorders Breakdown Data by Application
5.1 Global Gene Therapy for Inherited Genetic Disorders Historic Market Size by Application (2016-2021)
5.2 Global Gene Therapy for Inherited Genetic Disorders Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Gene Therapy for Inherited Genetic Disorders Market Size (2016-2027)
6.2 North America Gene Therapy for Inherited Genetic Disorders Market Size by Type
6.2.1 North America Gene Therapy for Inherited Genetic Disorders Market Size by Type (2016-2021)
6.2.2 North America Gene Therapy for Inherited Genetic Disorders Market Size by Type (2022-2027)
6.2.3 North America Gene Therapy for Inherited Genetic Disorders Market Size by Type (2016-2027)
6.3 North America Gene Therapy for Inherited Genetic Disorders Market Size by Application
6.3.1 North America Gene Therapy for Inherited Genetic Disorders Market Size by Application (2016-2021)
6.3.2 North America Gene Therapy for Inherited Genetic Disorders Market Size by Application (2022-2027)
6.3.3 North America Gene Therapy for Inherited Genetic Disorders Market Size by Application (2016-2027)
6.4 North America Gene Therapy for Inherited Genetic Disorders Market Size by Country
6.4.1 North America Gene Therapy for Inherited Genetic Disorders Market Size by Country (2016-2021)
6.4.2 North America Gene Therapy for Inherited Genetic Disorders Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Gene Therapy for Inherited Genetic Disorders Market Size (2016-2027)
7.2 Europe Gene Therapy for Inherited Genetic Disorders Market Size by Type
7.2.1 Europe Gene Therapy for Inherited Genetic Disorders Market Size by Type (2016-2021)
7.2.2 Europe Gene Therapy for Inherited Genetic Disorders Market Size by Type (2022-2027)
7.2.3 Europe Gene Therapy for Inherited Genetic Disorders Market Size by Type (2016-2027)
7.3 Europe Gene Therapy for Inherited Genetic Disorders Market Size by Application
7.3.1 Europe Gene Therapy for Inherited Genetic Disorders Market Size by Application (2016-2021)
7.3.2 Europe Gene Therapy for Inherited Genetic Disorders Market Size by Application (2022-2027)
7.3.3 Europe Gene Therapy for Inherited Genetic Disorders Market Size by Application (2016-2027)
7.4 Europe Gene Therapy for Inherited Genetic Disorders Market Size by Country
7.4.1 Europe Gene Therapy for Inherited Genetic Disorders Market Size by Country (2016-2021)
7.4.2 Europe Gene Therapy for Inherited Genetic Disorders Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Gene Therapy for Inherited Genetic Disorders Market Size (2016-2027)
8.2 Asia-Pacific Gene Therapy for Inherited Genetic Disorders Market Size by Type
8.2.1 Asia-Pacific Gene Therapy for Inherited Genetic Disorders Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Gene Therapy for Inherited Genetic Disorders Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Gene Therapy for Inherited Genetic Disorders Market Size by Type (2016-2027)
8.3 Asia-Pacific Gene Therapy for Inherited Genetic Disorders Market Size by Application
8.3.1 Asia-Pacific Gene Therapy for Inherited Genetic Disorders Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Gene Therapy for Inherited Genetic Disorders Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Gene Therapy for Inherited Genetic Disorders Market Size by Application (2016-2027)
8.4 Asia-Pacific Gene Therapy for Inherited Genetic Disorders Market Size by Region
8.4.1 Asia-Pacific Gene Therapy for Inherited Genetic Disorders Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Gene Therapy for Inherited Genetic Disorders Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Gene Therapy for Inherited Genetic Disorders Market Size (2016-2027)
9.2 Latin America Gene Therapy for Inherited Genetic Disorders Market Size by Type
9.2.1 Latin America Gene Therapy for Inherited Genetic Disorders Market Size by Type (2016-2021)
9.2.2 Latin America Gene Therapy for Inherited Genetic Disorders Market Size by Type (2022-2027)
9.2.3 Latin America Gene Therapy for Inherited Genetic Disorders Market Size by Type (2016-2027)
9.3 Latin America Gene Therapy for Inherited Genetic Disorders Market Size by Application
9.3.1 Latin America Gene Therapy for Inherited Genetic Disorders Market Size by Application (2016-2021)
9.3.2 Latin America Gene Therapy for Inherited Genetic Disorders Market Size by Application (2022-2027)
9.3.3 Latin America Gene Therapy for Inherited Genetic Disorders Market Size by Application (2016-2027)
9.4 Latin America Gene Therapy for Inherited Genetic Disorders Market Size by Country
9.4.1 Latin America Gene Therapy for Inherited Genetic Disorders Market Size by Country (2016-2021)
9.4.2 Latin America Gene Therapy for Inherited Genetic Disorders Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size (2016-2027)
10.2 Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size by Type
10.2.1 Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size by Type (2016-2027)
10.3 Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size by Application
10.3.1 Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size by Application (2016-2027)
10.4 Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size by Country
10.4.1 Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 BioMarin Pharmaceutical Inc.
11.1.1 BioMarin Pharmaceutical Inc. Company Details
11.1.2 BioMarin Pharmaceutical Inc. Business Overview
11.1.3 BioMarin Pharmaceutical Inc. Gene Therapy for Inherited Genetic Disorders Introduction
11.1.4 BioMarin Pharmaceutical Inc. Revenue in Gene Therapy for Inherited Genetic Disorders Business (2016-2021)
11.1.5 BioMarin Pharmaceutical Inc. Recent Development
11.2 bluebird bio Inc.
11.2.1 bluebird bio Inc. Company Details
11.2.2 bluebird bio Inc. Business Overview
11.2.3 bluebird bio Inc. Gene Therapy for Inherited Genetic Disorders Introduction
11.2.4 bluebird bio Inc. Revenue in Gene Therapy for Inherited Genetic Disorders Business (2016-2021)
11.2.5 bluebird bio Inc. Recent Development
11.3 Novartis AG
11.3.1 Novartis AG Company Details
11.3.2 Novartis AG Business Overview
11.3.3 Novartis AG Gene Therapy for Inherited Genetic Disorders Introduction
11.3.4 Novartis AG Revenue in Gene Therapy for Inherited Genetic Disorders Business (2016-2021)
11.3.5 Novartis AG Recent Development
11.4 Orchard Therapeutics Plc
11.4.1 Orchard Therapeutics Plc Company Details
11.4.2 Orchard Therapeutics Plc Business Overview
11.4.3 Orchard Therapeutics Plc Gene Therapy for Inherited Genetic Disorders Introduction
11.4.4 Orchard Therapeutics Plc Revenue in Gene Therapy for Inherited Genetic Disorders Business (2016-2021)
11.4.5 Orchard Therapeutics Plc Recent Development
11.5 Spark Therapeutics Inc.
11.5.1 Spark Therapeutics Inc. Company Details
11.5.2 Spark Therapeutics Inc. Business Overview
11.5.3 Spark Therapeutics Inc. Gene Therapy for Inherited Genetic Disorders Introduction
11.5.4 Spark Therapeutics Inc. Revenue in Gene Therapy for Inherited Genetic Disorders Business (2016-2021)
11.5.5 Spark Therapeutics Inc. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Gene Therapy for Inherited Genetic Disorders Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Eye Disorders
Table 3. Key Players of Hematological Disorders
Table 4. Key Players of Central Nervous System Disorders
Table 5. Key Players of Muscular Disorders
Table 6. Key Players of Others
Table 7. Global Gene Therapy for Inherited Genetic Disorders Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Gene Therapy for Inherited Genetic Disorders Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Gene Therapy for Inherited Genetic Disorders Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Gene Therapy for Inherited Genetic Disorders Market Share by Regions (2016-2021)
Table 11. Global Gene Therapy for Inherited Genetic Disorders Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Gene Therapy for Inherited Genetic Disorders Market Share by Regions (2022-2027)
Table 13. Gene Therapy for Inherited Genetic Disorders Market Trends
Table 14. Gene Therapy for Inherited Genetic Disorders Market Drivers
Table 15. Gene Therapy for Inherited Genetic Disorders Market Challenges
Table 16. Gene Therapy for Inherited Genetic Disorders Market Restraints
Table 17. Global Gene Therapy for Inherited Genetic Disorders Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Gene Therapy for Inherited Genetic Disorders Market Share by Players (2016-2021)
Table 19. Global Top Gene Therapy for Inherited Genetic Disorders Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene Therapy for Inherited Genetic Disorders as of 2020)
Table 20. Ranking of Global Top Gene Therapy for Inherited Genetic Disorders Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Gene Therapy for Inherited Genetic Disorders Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Gene Therapy for Inherited Genetic Disorders Product Solution and Service
Table 24. Date of Enter into Gene Therapy for Inherited Genetic Disorders Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Gene Therapy for Inherited Genetic Disorders Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Gene Therapy for Inherited Genetic Disorders Revenue Market Share by Type (2016-2021)
Table 28. Global Gene Therapy for Inherited Genetic Disorders Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Gene Therapy for Inherited Genetic Disorders Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Gene Therapy for Inherited Genetic Disorders Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Gene Therapy for Inherited Genetic Disorders Revenue Market Share by Application (2016-2021)
Table 32. Global Gene Therapy for Inherited Genetic Disorders Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Gene Therapy for Inherited Genetic Disorders Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Gene Therapy for Inherited Genetic Disorders Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Gene Therapy for Inherited Genetic Disorders Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Gene Therapy for Inherited Genetic Disorders Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Gene Therapy for Inherited Genetic Disorders Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Gene Therapy for Inherited Genetic Disorders Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Gene Therapy for Inherited Genetic Disorders Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Gene Therapy for Inherited Genetic Disorders Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Gene Therapy for Inherited Genetic Disorders Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Gene Therapy for Inherited Genetic Disorders Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Gene Therapy for Inherited Genetic Disorders Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Gene Therapy for Inherited Genetic Disorders Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Gene Therapy for Inherited Genetic Disorders Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Gene Therapy for Inherited Genetic Disorders Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Gene Therapy for Inherited Genetic Disorders Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Gene Therapy for Inherited Genetic Disorders Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Gene Therapy for Inherited Genetic Disorders Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Gene Therapy for Inherited Genetic Disorders Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Gene Therapy for Inherited Genetic Disorders Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Gene Therapy for Inherited Genetic Disorders Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Gene Therapy for Inherited Genetic Disorders Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Gene Therapy for Inherited Genetic Disorders Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Gene Therapy for Inherited Genetic Disorders Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Gene Therapy for Inherited Genetic Disorders Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Gene Therapy for Inherited Genetic Disorders Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size by Country (2022-2027) & (US$ Million)
Table 64. BioMarin Pharmaceutical Inc. Company Details
Table 65. BioMarin Pharmaceutical Inc. Business Overview
Table 66. BioMarin Pharmaceutical Inc. Gene Therapy for Inherited Genetic Disorders Product
Table 67. BioMarin Pharmaceutical Inc. Revenue in Gene Therapy for Inherited Genetic Disorders Business (2016-2021) & (US$ Million)
Table 68. BioMarin Pharmaceutical Inc. Recent Development
Table 69. bluebird bio Inc. Company Details
Table 70. bluebird bio Inc. Business Overview
Table 71. bluebird bio Inc. Gene Therapy for Inherited Genetic Disorders Product
Table 72. bluebird bio Inc. Revenue in Gene Therapy for Inherited Genetic Disorders Business (2016-2021) & (US$ Million)
Table 73. bluebird bio Inc. Recent Development
Table 74. Novartis AG Company Details
Table 75. Novartis AG Business Overview
Table 76. Novartis AG Gene Therapy for Inherited Genetic Disorders Product
Table 77. Novartis AG Revenue in Gene Therapy for Inherited Genetic Disorders Business (2016-2021) & (US$ Million)
Table 78. Novartis AG Recent Development
Table 79. Orchard Therapeutics Plc Company Details
Table 80. Orchard Therapeutics Plc Business Overview
Table 81. Orchard Therapeutics Plc Gene Therapy for Inherited Genetic Disorders Product
Table 82. Orchard Therapeutics Plc Revenue in Gene Therapy for Inherited Genetic Disorders Business (2016-2021) & (US$ Million)
Table 83. Orchard Therapeutics Plc Recent Development
Table 84. Spark Therapeutics Inc. Company Details
Table 85. Spark Therapeutics Inc. Business Overview
Table 86. Spark Therapeutics Inc. Gene Therapy for Inherited Genetic Disorders Product
Table 87. Spark Therapeutics Inc. Revenue in Gene Therapy for Inherited Genetic Disorders Business (2016-2021) & (US$ Million)
Table 88. Spark Therapeutics Inc. Recent Development
Table 89. Research Programs/Design for This Report
Table 90. Key Data Information from Secondary Sources
Table 91. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gene Therapy for Inherited Genetic Disorders Market Share by Type: 2020 VS 2027
Figure 2. Eye Disorders Features
Figure 3. Hematological Disorders Features
Figure 4. Central Nervous System Disorders Features
Figure 5. Muscular Disorders Features
Figure 6. Others Features
Figure 7. Global Gene Therapy for Inherited Genetic Disorders Market Share by Application: 2020 VS 2027
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Research Institute Case Studies
Figure 11. Others Case Studies
Figure 12. Gene Therapy for Inherited Genetic Disorders Report Years Considered
Figure 13. Global Gene Therapy for Inherited Genetic Disorders Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Gene Therapy for Inherited Genetic Disorders Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Gene Therapy for Inherited Genetic Disorders Market Share by Regions: 2020 VS 2027
Figure 16. Global Gene Therapy for Inherited Genetic Disorders Market Share by Regions (2022-2027)
Figure 17. Global Gene Therapy for Inherited Genetic Disorders Market Share by Players in 2020
Figure 18. Global Top Gene Therapy for Inherited Genetic Disorders Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene Therapy for Inherited Genetic Disorders as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Gene Therapy for Inherited Genetic Disorders Revenue in 2020
Figure 20. Global Gene Therapy for Inherited Genetic Disorders Revenue Market Share by Type (2016-2021)
Figure 21. Global Gene Therapy for Inherited Genetic Disorders Revenue Market Share by Type (2022-2027)
Figure 22. North America Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Gene Therapy for Inherited Genetic Disorders Market Share by Type (2016-2027)
Figure 24. North America Gene Therapy for Inherited Genetic Disorders Market Share by Application (2016-2027)
Figure 25. North America Gene Therapy for Inherited Genetic Disorders Market Share by Country (2016-2027)
Figure 26. United States Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Gene Therapy for Inherited Genetic Disorders Market Share by Type (2016-2027)
Figure 30. Europe Gene Therapy for Inherited Genetic Disorders Market Share by Application (2016-2027)
Figure 31. Europe Gene Therapy for Inherited Genetic Disorders Market Share by Country (2016-2027)
Figure 32. Germany Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Gene Therapy for Inherited Genetic Disorders Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Gene Therapy for Inherited Genetic Disorders Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Gene Therapy for Inherited Genetic Disorders Market Share by Region (2016-2027)
Figure 42. China Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Gene Therapy for Inherited Genetic Disorders Market Share by Type (2016-2027)
Figure 50. Latin America Gene Therapy for Inherited Genetic Disorders Market Share by Application (2016-2027)
Figure 51. Latin America Gene Therapy for Inherited Genetic Disorders Market Share by Country (2016-2027)
Figure 52. Mexico Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Share by Country (2016-2027)
Figure 58. Turkey Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Gene Therapy for Inherited Genetic Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. BioMarin Pharmaceutical Inc. Revenue Growth Rate in Gene Therapy for Inherited Genetic Disorders Business (2016-2021)
Figure 62. bluebird bio Inc. Revenue Growth Rate in Gene Therapy for Inherited Genetic Disorders Business (2016-2021)
Figure 63. Novartis AG Revenue Growth Rate in Gene Therapy for Inherited Genetic Disorders Business (2016-2021)
Figure 64. Orchard Therapeutics Plc Revenue Growth Rate in Gene Therapy for Inherited Genetic Disorders Business (2016-2021)
Figure 65. Spark Therapeutics Inc. Revenue Growth Rate in Gene Therapy for Inherited Genetic Disorders Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

---